FDA releases draft guidance on use-related risk analysis for combo products
Regulatory NewsJeff Craven
Combination products/companion diagnosticsGuidanceHuman factorsProduct developmentProduct LifecycleUnited StatesRegulatory NewsJeff CravenCombination products/companion diagnosticsGuidanceHuman factorsProduct developmentProduct LifecycleUnited States